Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Denise C. LaTemple"'
Autor:
Denise C. LaTemple, Grace Lin, Yvette M. Murley, Marlene O. Heeg, Steve Bender, Jonathan S. Simmons
Publikováno v:
Journal of the American College of Cardiology. 77:3342
Autor:
Denise C. LaTemple, Uri Galili
Publikováno v:
Xenotransplantation. 5:191-196
The knockout mouse to alpha1,3galactosyltransferase (alpha1,3GT KO) lacks the ability to synthesize alpha-gal epitopes (Galalpha1,3Galbeta1,4GlcNAc-R) and is capable of producing low amounts of the natural anti-Gal antibody. The present study indicat
Publikováno v:
Transplantation. 65:1129-1132
Background The assessment of a-gal epitope (Galalpha1-3Galbeta1-4GlcNAc-R) expression on various cells and tissues is important for the prediction of anti-Gal-mediated immune rejection of xenografts. This study describes an enzyme-linked immunosorben
Autor:
Denise C. LaTemple, Uri Galili
Publikováno v:
Immunology Today. 18:281-285
The immunogenicity of tumor-associated antigens (TAAs) in autologous tumor vaccines is usually very low. Here, the possibility is discussed that TAA immunogenicity might be increased in any human tumor-cell vaccine by engineering the vaccinating memb
Autor:
Uri Galili, Denise C. LaTemple
Publikováno v:
α-Gal and Anti-Gal ISBN: 9781461371601
Anti-Gal is considered to be the most prevalent naturally occurring antibody common to all humans. It represents approximately 1 % of total IgG in the serum in humans and interacts specifically with the α-gal epitope of cell surface glycoproteins an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cbc4ec93ca22bcc9a6be5cb8fc25b64
https://doi.org/10.1007/978-1-4615-4771-6_15
https://doi.org/10.1007/978-1-4615-4771-6_15
Publikováno v:
α-Gal and Anti-Gal ISBN: 9781461371601
Anti-Gal is the most abundant antibody found in humans. It constitutes 1 % of circulating antibodies and interacts specifically with the α-gal epitope (Galα1-3Galβl-4GlcNAc-R). This chapter describes the studies which have red to the identificatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03cd138c14a225d019e68df3659d7e1c
https://doi.org/10.1007/978-1-4615-4771-6_4
https://doi.org/10.1007/978-1-4615-4771-6_4
Autor:
William M. F. Lee, Michael S. Gee, Denise C. LaTemple, Joshua M. Farber, Xiaojing Ma, Sidney Pestka, Maria Wysocka, Kevin E. Salhany, Fang Liao, Christina M. Coughlin, Giorgia Gri, Serguei V. Kotenko, Li Liu, Giorgio Trinchieri, Ji Eun Kim
Publikováno v:
Immunity. (1):25-34
Expression of a dominant negative mutant IFNgammaR1 in murine SCK and K1735 tumor cells rendered them relatively unresponsive to IFNgamma in vitro and more tumorigenic and less responsive to IL-12 therapy in vivo. IL-12 induced histologic evidence of